Literature DB >> 27658774

Long non-coding RNA TUG1 contributes to tumorigenesis of human osteosarcoma by sponging miR-9-5p and regulating POU2F1 expression.

Chu-Hai Xie1, Yan-Ming Cao2, Yan Huang2, Qun-Wei Shi2, Jian-Hong Guo2, Zi-Wen Fan2, Ju-Gen Li2, Bin-Wei Chen2, Bo-Yi Wu2.   

Abstract

Recent studies have shown that long non-coding RNAs (lncRNAs) have critical roles in tumorigenesis, including osteosarcoma. The lncRNA taurine-upregulated gene 1 (TUG1) was reported to be involved in the progression of osteosarcoma. Here, we investigated the role of TUG1 in osteosarcoma cells and the underlying mechanism. TUG1 expression was measured in osteosarcoma cell lines and human normal osteoblast cells by quantitative real-time PCR (qRT-PCR). The effects of TUG1 on osteosarcoma cells were studied by RNA interference in vitro and in vivo. The mechanism of competing endogenous RNA (ceRNA) was determined using bioinformatic analysis and luciferase assays. Our data showed that TUG1 knockdown inhibited cell proliferation and colony formation, and induced G0/G1 cell cycle arrest and apoptosis in vitro, and suppressed tumor growth in vivo. Besides, we found that TUG1 acted as an endogenous sponge to directly bind to miR-9-5p and downregulated miR-9-5p expression. Moreover, TUG1 overturned the effect of miR-9-5p on the proliferation, colony formation, cell cycle arrest, and apoptosis in osteosarcoma cells, which involved the derepression of POU class 2 homeobox 1 (POU2F1) expression. In conclusion, our study elucidated a novel TUG1/miR-9-5p/POU2F1 pathway, in which TUG1 acted as a ceRNA by sponging miR-9-5p, leading to downregulation of POU2F1 and facilitating the tumorigenesis of osteosarcoma. These findings may contribute to the lncRNA-targeted therapy for human osteosarcoma.

Entities:  

Keywords:  Osteosarcoma; POU2F1; TUG1; ceRNA; miR-9-5p

Mesh:

Substances:

Year:  2016        PMID: 27658774     DOI: 10.1007/s13277-016-5391-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  26 in total

Review 1.  Molecular mechanisms of long noncoding RNAs.

Authors:  Kevin C Wang; Howard Y Chang
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

2.  Association of the POU class 2 homeobox 1 gene (POU2F1) with susceptibility to Type 2 diabetes in Chinese populations.

Authors:  M C Y Ng; V K L Lam; C H T Tam; A W H Chan; W-Y So; R C W Ma; B C Y Zee; M M Y Waye; W W Mak; C Hu; C R Wang; P C Y Tong; W P Jia; J C N Chan
Journal:  Diabet Med       Date:  2010-12       Impact factor: 4.359

Review 3.  From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis.

Authors:  Sonam Dhamija; Sven Diederichs
Journal:  Int J Cancer       Date:  2016-03-02       Impact factor: 7.396

4.  Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals.

Authors:  Mitchell Guttman; Ido Amit; Manuel Garber; Courtney French; Michael F Lin; David Feldser; Maite Huarte; Or Zuk; Bryce W Carey; John P Cassady; Moran N Cabili; Rudolf Jaenisch; Tarjei S Mikkelsen; Tyler Jacks; Nir Hacohen; Bradley E Bernstein; Manolis Kellis; Aviv Regev; John L Rinn; Eric S Lander
Journal:  Nature       Date:  2009-02-01       Impact factor: 49.962

5.  Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling.

Authors:  Bekim Sadikovic; Maisa Yoshimoto; Susan Chilton-MacNeill; Paul Thorner; Jeremy A Squire; Maria Zielenska
Journal:  Hum Mol Genet       Date:  2009-03-13       Impact factor: 6.150

Review 6.  The multilayered complexity of ceRNA crosstalk and competition.

Authors:  Yvonne Tay; John Rinn; Pier Paolo Pandolfi
Journal:  Nature       Date:  2014-01-16       Impact factor: 49.962

7.  Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.

Authors:  Paul A Meyers; Cindy L Schwartz; Mark D Krailo; John H Healey; Mark L Bernstein; Donna Betcher; William S Ferguson; Mark C Gebhardt; Allen M Goorin; Michael Harris; Eugenie Kleinerman; Michael P Link; Helen Nadel; Michael Nieder; Gene P Siegal; Michael A Weiner; Robert J Wells; Richard B Womer; Holcombe E Grier
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

8.  Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

9.  MicroRNA Involvement in Osteosarcoma.

Authors:  Eisuke Kobayashi; Francis J Hornicek; Zhenfeng Duan
Journal:  Sarcoma       Date:  2012-04-03

10.  Characterization of long non-coding RNA-associated ceRNA network to reveal potential prognostic lncRNA biomarkers in human ovarian cancer.

Authors:  Meng Zhou; Xiaojun Wang; Hongbo Shi; Liang Cheng; Zhenzhen Wang; Hengqiang Zhao; Lei Yang; Jie Sun
Journal:  Oncotarget       Date:  2016-03-15
View more
  67 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  [Specific microRNA expression profiles of lung adenocarcinoma in Xuanwei region and bioinformatic analysis for predicting their target genes and related signaling pathways].

Authors:  Shuai Chen; Yong-Chun Zhou; Ying Chen; Xiao-Bo Chen; Guang-Jian Li; Jia-Peng Yang; Yu-Jie Lei; Guang-Qiang Zhao; Qiu-Bo Huang; Chang-Shao Yang; Ya-Xi DU; Yun-Chao Huang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-02-20

Review 3.  Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma.

Authors:  Chongchong Wang; Juehua Jing; Li Cheng
Journal:  Invest New Drugs       Date:  2018-08-06       Impact factor: 3.850

4.  Long Noncoding RNA GAPLINC Promotes Cells Migration and Invasion in Colorectal Cancer Cell by Regulating miR-34a/c-MET Signal Pathway.

Authors:  Yuqi Luo; Jun Ouyang; Donggen Zhou; Shizhen Zhong; Minjie Wen; Wentao Ou; Haitao Yu; Lin Jia; Yaoxin Huang
Journal:  Dig Dis Sci       Date:  2018-02-09       Impact factor: 3.199

Review 5.  Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review).

Authors:  Stella Baliou; Anthony M Kyriakopoulos; Demetrios A Spandidos; Vassilios Zoumpourlis
Journal:  Int J Oncol       Date:  2020-07-14       Impact factor: 5.650

6.  Long non-coding RNA CCAT1 promotes multiple myeloma progression by acting as a molecular sponge of miR-181a-5p to modulate HOXA1 expression.

Authors:  Li Chen; Ning Hu; Chao Wang; Hongmian Zhao; Yueli Gu
Journal:  Cell Cycle       Date:  2018-01-29       Impact factor: 4.534

7.  POU2F1 promotes growth and metastasis of hepatocellular carcinoma through the FAT1 signaling pathway.

Authors:  Hong Yan Zhu; Guan Yi Cao; Shi Ping Wang; Yu Chen; Guo Dong Liu; Yu Jie Gao; Jian Ping Hu
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

8.  LINC00665/miR-9-5p/ATF1 is a novel axis involved in the progression of colorectal cancer.

Authors:  Xuhong Zhao; Wenhao Weng; Yin Long; Weijie Pan; Zhi Li; Fenyong Sun
Journal:  Hum Cell       Date:  2020-08-10       Impact factor: 4.174

9.  miR-9-5p facilitates hepatocellular carcinoma cell proliferation, migration and invasion by targeting ESR1.

Authors:  Libing Wang; Mingxin Cui; Daming Cheng; Fengzhi Qu; Jingkun Yu; Yanbin Wei; Ling Cheng; Xiaotang Wu; Xiaogang Liu
Journal:  Mol Cell Biochem       Date:  2020-10-27       Impact factor: 3.396

10.  POU2F1 Promotes Cell Viability and Tumor Growth in Gastric Cancer through Transcriptional Activation of lncRNA TTC3-AS1.

Authors:  Jixu Wang; Ke Xiao; Futao Hou; Lusheng Tang; Dan Luo; Gu Liu; Zhiqiang Wang
Journal:  J Oncol       Date:  2021-06-28       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.